3.5.2. carcinoma associated end-stage renal disease; acquired cystic disease-associated rcc. cystic degenerative changes (acquired cystic kidney disease [ackd]) higher incidence rcc, typical features esrd. renal cell carcinomas native end-stage kidneys found approximately 4% patients esrd. lifetime risk developing rccs least ten times higher general population. compared sporadic rccs, rccs associated esrd generally multicentric bilateral, found younger patients (mostly male), less aggressive. whether relatively indolent outcome tumours esrd due mode diagnosis specific ackd-related molecular pathway still determined. although histological spectrum esrd tumours like sporadic rcc; prcc occur relatively frequently . specific subtype rcc occurring end-stage kidneys described “acquired cystic disease-associated rcc” (acd-rcc). tumours present exclusively patients ackd, usually long-term dialysis. vast majority occur men. tumours often multiple bilateral and, cases, indolent clinical behaviour; although, aggressive courses documented .